Helicobacter pylori infection and gastric cancer.

Gastric cancer is the second most common fatal malignant neoplasm in the world. In mainland China, gastric cancer is now the second most common malignant neoplasm, while in Hong Kong the mortality rate ranked fourth of all cancers in 1995. Dietary factors seem to be involved in gastric carcinogenesis, and beta carotene, selenium, and vitamin E (tocopherols) have been shown to help reduce gastric cancer mortality. Prospective case-control studies have shown an increased risk for the development of gastric cancer of between 2.8 and 6.0 among carriers of Helicobacter pylori. In addition, cagA-positive strains of Helicobacter pylori have been found to be associated with gastric cancer and duodenal ulceration. The exact role of Helicobacter pylori in gastric carcinogenesis is still being investigated. Helicobacter pylori eradication programmes to help prevent gastric cancer are being conducted in China and other parts of the world. In high-risk areas such as China, a combination approach that includes Helicobacter pylori eradication and dietary supplementation may be necessary.

[1]  Z. Gao,et al.  Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China , 1999, Journal of gastroenterology and hepatology.

[2]  S. Hazell,et al.  Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. , 1996, The American journal of gastroenterology.

[3]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[4]  D. Tompkins,et al.  Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. , 1993, Gut.

[5]  N. Muñoz,et al.  Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  Alter Mj,et al.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.

[7]  D. Forman,et al.  Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China , 1990, International journal of cancer.

[8]  P. Sipponen,et al.  Helicobacter pylori infection and chronic gastritis in gastric cancer. , 1992, Journal of clinical pathology.

[9]  R. Doll.  Cancer in Five Continents , 1972, Proceedings of the Royal Society of Medicine.

[10]  G. Friedman,et al.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. , 1997, Gut.

[11]  S. Lam,et al.  Helicobacter pylori epidemiology in relation to peptic ulcer and gastric cancer in South and North China , 1994, Journal of gastroenterology and hepatology.

[12]  N. Muñoz,et al.  Prevalence of precancerous lesions of the stomach in Venezuela. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  C. O'Morain,et al.  Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. , 1996, Gut.

[14]  E. Kuipers,et al.  Helicobacter pylori serology in patients with gastric carcinoma. , 1993, Scandinavian journal of gastroenterology.

[15]  D. Graham,et al.  Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. , 1991, Gastroenterology.

[16]  M. Gail,et al.  Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. , 1998, Controlled clinical trials.

[17]  B. C. Wong,et al.  Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. , 1996, The American journal of gastroenterology.

[18]  L. Hansson,et al.  Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. , 1993, Gastroenterology.

[19]  M. Blaser,et al.  Helicobacter pylori infection in japanese patients with adenocarcinoma of the stomach , 1993, International journal of cancer.

[20]  T. A. S. Group.  An international association between Helicobacter pylori infection and gastric cancer , 1993, The Lancet.

[21]  P. Davaris,et al.  Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. , 1993, The Italian journal of gastroenterology.

[22]  R. Rappuoli,et al.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. McColl,et al.  Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. , 1994, Gut.

[24]  J. Sigurjónsson.  Occupational variations in mortality from gastric cancer in relation to dietary differences. , 1967, British Journal of Cancer.

[25]  W. Leung,et al.  Effects of curing Helicobacter pylori infection on precancerous gastric lesions: One-year follow-up of a prospective randomized study in China , 1998 .

[26]  A. Lilienfeld,et al.  Genetic studies of gastric cancer in humans: An appraisal , 1958, Cancer.

[27]  M. Blaser,et al.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.

[28]  D. Amadori,et al.  Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  B. Henderson,et al.  Diet and high risk of stomach cancer in Shandong, China. , 1988, Cancer research.

[30]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[31]  D. Graham,et al.  Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. , 1996, American Journal of Gastroenterology.

[32]  G. R. Davies,et al.  Helicobacter pylori, free radicals and gastroduodenal disease , 1994 .

[33]  P. Taylor,et al.  Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. , 1993, Journal of the National Cancer Institute.

[34]  E. Fontham,et al.  Helicobacter pylori and gastric carcinoma: Serum antibody prevalence in populations with contrasting cancer risks , 1990, Cancer.

[35]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[36]  C. N. Leitão,et al.  Anti‐Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case‐control study , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[37]  S. Greenhalgh.  Diet, Life-style and Mortality in China: A Study of the Characteristics of 65 Chinese Counties , 1992 .

[38]  D. Forman,et al.  H pylori and gastric cancer , 1994, The Lancet.

[39]  S. Kikuchi,et al.  Serum anti‐Helicobacter pylori antibody and gastric carcinoma among young adults , 1995 .

[40]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[41]  M. Blaser,et al.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.

[42]  田島 和雄.  Dietary habits and gastro-intestinal cancers : a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan , 1986 .

[43]  M. Blaser,et al.  Gastric adenocarcinoma and Helicobacter pylori infection. , 1991, Journal of the National Cancer Institute.

[44]  D. Amadori,et al.  Methodological Issues in a Multicentric Study of Gastric Cancer and Diet in Italy: Study Design, Data Sources and Quality Controls , 1989, Tumori.

[45]  M. Blaser,et al.  CagA and the outcome of Helicobacter pylori infection. , 1996, American journal of clinical pathology.

[46]  Lin Hz.  Campylobacter pyloridis (Cp) infection of gastric mucosa in the high and low risk areas of gastric cancer in Liaoning province , 1989 .

[47]  P. I. Reed,et al.  Primary prevention of gastric precancerous lesions. , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.